170 related articles for article (PubMed ID: 2402772)
21. Inactivation of hepatitis B and Hutchinson strain non-A, non-B hepatitis viruses by exposure to Tween 80 and ether.
Prince AM; Horowitz B; Brotman B; Huima T; Richardson L; van den Ende MC
Vox Sang; 1984; 46(1):36-43. PubMed ID: 6422634
[TBL] [Abstract][Full Text] [Related]
22. Inability of solvent-detergent (S-D) treated factor VIII concentrate to inactivate parvoviruses and non-lipid enveloped non-A, non-B hepatitis virus in factor VIII concentrate: advantages to using sterilizing 100 degrees C dry heat treatment.
Rubinstein AI; Rubinstein DB
Am J Hematol; 1990 Oct; 35(2):142. PubMed ID: 2119141
[No Abstract] [Full Text] [Related]
23. Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results.
Piquet Y; Janvier G; Selosse P; Doutremepuich C; Jouneau J; Nicolle G; Platel D; Vezon G
Vox Sang; 1992; 63(4):251-6. PubMed ID: 1336258
[TBL] [Abstract][Full Text] [Related]
24. Investigations into the application of tri(n-butyl)phosphate/detergent mixtures to blood derivatives.
Horowitz B
Curr Stud Hematol Blood Transfus; 1989; (56):83-96. PubMed ID: 2642786
[No Abstract] [Full Text] [Related]
25. Inactivation and removal of human immunodeficiency virus in monoclonal purified antihemophilic factor (human) (Hemofil M).
Piszkiewicz D; Sun CS; Tondreau SC
Thromb Res; 1989 Sep; 55(5):627-34. PubMed ID: 2510362
[TBL] [Abstract][Full Text] [Related]
26. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
Gürtler L
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
[TBL] [Abstract][Full Text] [Related]
27. Viral safety of solvent/detergent-treated blood products.
Horowitz B; Prince AM; Hamman J; Watklevicz C
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S21-8; discussion S29-S30. PubMed ID: 7749045
[TBL] [Abstract][Full Text] [Related]
28. Disruption of influenza virus A by diethylether-Tween and tri-N-butyl phosphate-Tween mixtures.
Danihelková H; Závadová H
Acta Virol; 1984 Jan; 28(1):26-32. PubMed ID: 6143494
[TBL] [Abstract][Full Text] [Related]
29. Sindbis virus as a tool for quality control of viral inactivation of heated and chemically treated plasma-derived products.
Espíndola OM; Belluci MS; Oliveira BC; Liberto MI; Cabral MC
J Virol Methods; 2006 Jun; 134(1-2):171-5. PubMed ID: 16507321
[TBL] [Abstract][Full Text] [Related]
30. TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.
Chou ML; Burnouf T; Chang SP; Hung TC; Lin CC; Richardson CD; Lin LT
PLoS One; 2015; 10(2):e0117800. PubMed ID: 25658612
[TBL] [Abstract][Full Text] [Related]
31. Purification of fibroblast growth factor-2 from human placenta using tri(n-butyl)phosphate and sodium cholate.
Wolff P; Tanaka AM; Chenker E; Cabrera-Crespo J; Raw I; Ho PL
Biochimie; 1996; 78(3):190-4. PubMed ID: 8831950
[TBL] [Abstract][Full Text] [Related]
32. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
Michalski C; Bal F; Burnouf T; Goudemand M
Vox Sang; 1988; 55(4):202-10. PubMed ID: 3265237
[TBL] [Abstract][Full Text] [Related]
33. Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate.
Roberts PL; Dunkerley C
Vox Sang; 2003 Apr; 84(3):170-5. PubMed ID: 12670365
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.
Feinstone SM; Mihalik KB; Kamimura T; Alter HJ; London WT; Purcell RH
Infect Immun; 1983 Aug; 41(2):816-21. PubMed ID: 6409813
[TBL] [Abstract][Full Text] [Related]
35. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
36. Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate 20.
Roberts PL; Lloyd D; Marshall PJ
Biologicals; 2009 Jan; 37(1):26-31. PubMed ID: 18848782
[TBL] [Abstract][Full Text] [Related]
37. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors.
Burnouf T; Tseng YH; Kuo YP; Su CY
Transfusion; 2008 Jun; 48(6):1090-8. PubMed ID: 18373502
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Prince AM; Stephan W; Kotitschke R; Brotman B
Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
[TBL] [Abstract][Full Text] [Related]
39. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
Schwinn H; Smith A; Wolter D
Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
Stephan W
Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
